# Medicus AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medicus-ai

- Industry: Software
- Headquarters: Vienna, Austria
- Website: www.medicus.ai
- Total disclosed funding: $25M
- Latest round: Series B (Dec 4, 2019)
- Investors on record: 5

## About

Medicus AI GmbH is a healthcare technology company that leverages artificial intelligence to enhance diagnostics and health management, providing innovative solutions for healthcare providers and patients alike.Medicus AI GmbH, founded in 2015, is based in Vienna, Austria, and specializes in AI-driven healthcare solutions aimed at improving diagnostic processes. The company has engaged in four deals, with the most recent funding round occurring on December 4, 2019. Medicus AI raised EUR 18.050 million in SERIES B funding, led by Sunhope Capital. The company was founded by Nadine Nehme, and its current CEO is Baher Hakim.Medicus AI offers a range of AI-powered healthcare solutions that aim to enhance the diagnostic process and improve patient management. Their key products include Smart Reports, which optimize reporting for healthcare providers, Smart Wellbeing, which provides health coaching and daily engagement tools, and HomeWell, designed for at-home health experiences, particularly for pregnant women and individuals seeking comfortable care at home. Medicus AI operates in 14 different markets globally and serves approximately 35 million patients through partnerships with various healthcare providers.Medicus AI generates revenue through B2B partnerships with healthcare providers, insurance companies, and diagnostic labs, utilizing a subscription model for its core products. Their services include Smart Reports and Smart Wellbeing, facilitating integration into existing healthcare systems while enhancing patient care and operational efficiency. Revenue structures are defined by service agreements that establish pricing, usage terms, and support services to ensure collaborative healthcare delivery.Medicus AI plans to utilize the EUR 18.051 million raised in its most recent SERIES B funding to develop new products and expand into additional markets. The company is focused on enhancing its current offerings and launching new solutions tailored to emerging healthcare needs. Further strategic initiatives include targeting expansion into new geographic regions, although specific locations have yet to be disclosed. These efforts are aimed at leveraging their innovative technology to broaden their reach within the healthcare sector.

## Funding rounds

- Series B, Dec 4, 2019, $20M — Sunhope Capital
- Series A, Feb 4, 2019, $3.2M — Die Bruckenkopfe, Atieh Capital GmbH, Biopart
- Seed, Jan 1, 2018, $1.2M — Speedinvest
- Seed, May 12, 2016, $0.7M — Sunhope Capital

## Investors

- Sunhope Capital (https://capitalatlas.ai/funds/sunhope-capital) — Seed, Series B
- Speedinvest (https://capitalatlas.ai/funds/speedinvest) — Seed
- Die Bruckenkopfe (https://capitalatlas.ai/funds/die-bruckenkopfe) — Series A
- Atieh Capital GmbH — Series A
- Biopart — Series A